Bruce D Hammock

Inventor

Add to Portfolio

Stats

Details

Work History

Patent OwnerApplications FiledYear
GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUM
1
2011
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
1
1
1
1
2000
2003
2005
2009
ARETE THERAPEUTICS
2
2007
UNIVERSIDAD POLITECNICA DE VALENCIA, A UNIVERSITY IN SPAIN
1
1998
MEDICAL COLLEGE OF GEORGIA
1
2005
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
2
1
1
2
5
1
6
2
3
2
7
4
3
6
10
8
3
5
5
8
5
8
2
1983
1988
1992
1993
1995
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2015
THE TEXAS A&M UNIVERSITY SYSTEM
1
2007
THE TRUSTEES OF DARTMOUTH COLLEGE
1
1
2013
2015
Texas A&M
1
2007
MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE, INC.
1
2005
NORTHWESTERN UNIVERSITY
1
2010
Universidad Politecnica De Valencia
1
1998
BASF AKTIENGESELLSCHAFT
1
1
1995
2007
SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE
2
2
2
2002
2007
2010

Inventor Addresses

AddressDuration
DAVIS, CA, USJan 27, 11 - Jan 27, 11
Davis, CADec 10, 85 - Nov 13, 08
Davis, CA, USMar 13, 03 - Mar 18, 25

Technology Profile

Technology Matters
A01H: NEW PLANTS OR PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES 3
A01K: ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS 3
A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 12

See more…

Patents / Publication

Patents / Publication #Year of Publication / IssuedTitleCitations
122513792025Methods of inhibiting formation of alpha synuclein aggregates0
120063552024Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif)0
119875422024Co-crystal of sorafenib derivatives and process for preparation thereof0
2024/0024,3022024SOLUBLE EPOXIDE HYDROLASE (sEH) INHIBITORS AND DUAL COX/sEH INHIBITORS FOR THE TREATMENT OF ARRHYTHMOGENIC CARDIOMYOPATHY0
2023/0301,9492023TREATMENT OF NEURODEVELOPMENTAL DISORDERS0

See more…


We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
> Upgrade to our Level for up to -1 portfolios!.